Sign Up to like & get
recommendations!
1
Published in 2022 at "Molecules"
DOI: 10.3390/molecules27196666
Abstract: Glioblastoma multiforme (GBM) is the most common and malignant brain tumor. Temozolomide (TMZ) is the first-line chemotherapeutic drug for treating GBM. However, drug resistance is still a challenging issue in GBM therapy. Our preliminary results…
read more here.
Keywords:
glioblastoma cells;
glioblastoma;
resistant sensitive;
drug resistant ... See more keywords